Table of Contents

company-logo

Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.

Hanall Biopharma Dividend Announcement

• Hanall Biopharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Hanall Biopharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Hanall Biopharma Dividend History

Hanall Biopharma Dividend Yield

Hanall Biopharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Hanall Biopharma stock? Use our calculator to estimate your expected dividend yield:

Hanall Biopharma Financial Ratios

P/E ratio-280.39
PEG ratio2.02
P/B ratio10.29
ROE-3.56%
Payout ratio0.00%
Current ratio2.86
Quick ratio2.86
Cash Ratio0.00

Hanall Biopharma Dividend FAQ

Does Hanall Biopharma stock pay dividends?
Hanall Biopharma does not currently pay dividends to its shareholders.
Has Hanall Biopharma ever paid a dividend?
No, Hanall Biopharma has no a history of paying dividends to its shareholders. Hanall Biopharma is not known for its dividend payments.
Why doesn't Hanall Biopharma pay dividends?
There are several potential reasons why Hanall Biopharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Hanall Biopharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Hanall Biopharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Hanall Biopharma a dividend aristocrat?
Hanall Biopharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Hanall Biopharma a dividend king?
Hanall Biopharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Hanall Biopharma a dividend stock?
No, Hanall Biopharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Hanall Biopharma stocks?
To buy Hanall Biopharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Hanall Biopharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.